Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Andrews

Showing results (91-100 of 364) with videos related to

Pageof 37
Sort By:
Plos One|November 26, 2014
The burden of disease and health care use among pertussis cases in school aged children and adults in England and Wales; a patient surveyAlbert Jan van Hoek, Helen Campbell, Nick Andrews, et al.
Vaccine|October 27, 2019
Protection provided by influenza vaccine against influenza-related hospitalisation in ≥65 year olds: Early experience of introduction of a newly licensed adjuvanted vaccine in England in 2018/19Richard Pebody, Heather Whitaker, Hongxin Zhao, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 10, 2019
Serogroup C <i>Neisseria meningitidis</i> disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16Helen Findlow, Helen Campbell, Jay Lucidarme, et al.
Vaccine|February 5, 2011
No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in EnglandRichard Pebody, Nick Andrews, Pauline Waight, et al.
Plos One|March 5, 2011
Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimationMarc Baguelin, Katja Hoschler, Elaine Stanford, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2022
Clinical Risk Factors Associated With Late-Onset Invasive Group B Streptococcal Disease: Systematic Review and Meta-AnalysesKonstantinos Karampatsas, Hannah Davies, Maren Mynarek, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 24, 2020
All-cause excess mortality observed by age group and regions in the first wave of the COVID-19 pandemic in EnglandMary A Sinnathamby, Heather Whitaker, Laura Coughlan, et al.
Human Vaccines|November 15, 2006
Reactogenicity of meningococcal C conjugate vaccines when administered at the same time as, or a month prior to or after, tetanus and diphtheria booster vaccinationsJo Southern, David Gelb, Nick Andrews, et al.
BMJ (Clinical Research Ed.)|February 28, 2013
Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysisElizabeth Miller, Nick Andrews, Lesley Stellitano, et al.
BMC Infectious Diseases|May 22, 2016
Working conditions and tuberculosis mortality in England and Wales, 1890-1912: a retrospective analysis of routinely collected dataCharlotte Jackson, Joanna H Mostowy, Helen R Stagg, et al.
Pageof 37

Showing results (91-100 of 364) with videos related to

Sort By:
Pageof 37
Plos One|November 26, 2014
The burden of disease and health care use among pertussis cases in school aged children and adults in England and Wales; a patient surveyAlbert Jan van Hoek, Helen Campbell, Nick Andrews, et al.
Vaccine|October 27, 2019
Protection provided by influenza vaccine against influenza-related hospitalisation in ≥65 year olds: Early experience of introduction of a newly licensed adjuvanted vaccine in England in 2018/19Richard Pebody, Heather Whitaker, Hongxin Zhao, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 10, 2019
Serogroup C <i>Neisseria meningitidis</i> disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16Helen Findlow, Helen Campbell, Jay Lucidarme, et al.
Vaccine|February 5, 2011
No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in EnglandRichard Pebody, Nick Andrews, Pauline Waight, et al.
Plos One|March 5, 2011
Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimationMarc Baguelin, Katja Hoschler, Elaine Stanford, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2022
Clinical Risk Factors Associated With Late-Onset Invasive Group B Streptococcal Disease: Systematic Review and Meta-AnalysesKonstantinos Karampatsas, Hannah Davies, Maren Mynarek, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 24, 2020
All-cause excess mortality observed by age group and regions in the first wave of the COVID-19 pandemic in EnglandMary A Sinnathamby, Heather Whitaker, Laura Coughlan, et al.
Human Vaccines|November 15, 2006
Reactogenicity of meningococcal C conjugate vaccines when administered at the same time as, or a month prior to or after, tetanus and diphtheria booster vaccinationsJo Southern, David Gelb, Nick Andrews, et al.
BMJ (Clinical Research Ed.)|February 28, 2013
Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysisElizabeth Miller, Nick Andrews, Lesley Stellitano, et al.
BMC Infectious Diseases|May 22, 2016
Working conditions and tuberculosis mortality in England and Wales, 1890-1912: a retrospective analysis of routinely collected dataCharlotte Jackson, Joanna H Mostowy, Helen R Stagg, et al.
Pageof 37